BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16651502)

  • 21. Prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose.
    Florkowski CM; Beaven DW
    N Z Med J; 2007 Aug; 120(1259):U2674. PubMed ID: 17721578
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence and impact of cardiovascular risk factors in Bucaramanga, Colombia: results from the Countrywide Integrated Noncommunicable Disease Intervention Programme (CINDI/CARMEN) baseline survey.
    Bautista LE; Oróstegui M; Vera LM; Prada GE; Orozco LC; Herrán OF
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):769-75. PubMed ID: 17001217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of different markers of socioeconomic status with cardiovascular disease and diabetes risk factors in the Diabetes, Heart and Health Survey.
    Metcalf PA; Scragg RR; Schaaf D; Dyall L; Black PN; Jackson RT
    N Z Med J; 2008 Feb; 121(1269):45-56. PubMed ID: 18278081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk--the Shape of the Nations survey.
    Smith SC; Haslam D
    Curr Med Res Opin; 2007 Jan; 23(1):29-47. PubMed ID: 17261236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fasting glucose and cardiovascular risk factors in an urban population.
    Gupta R; Sarna M; Thanvi J; Sharma V; Gupta VP
    J Assoc Physicians India; 2007 Oct; 55():705-9. PubMed ID: 18173023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004.
    Gregg EW; Cheng YJ; Narayan KM; Thompson TJ; Williamson DF
    Prev Med; 2007 Nov; 45(5):348-52. PubMed ID: 17889292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose.
    McCallum RW; Parameswaran V; Burgess JR
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):163-8. PubMed ID: 16886955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staged diabetes management. Toward an integrated model of diabetes care.
    Mazze RS; Etzwiler DD; Strock E; Peterson K; McClave CR; Meszaros JF; Leigh C; Owens LW; Deeb LC; Peterson A
    Diabetes Care; 1994 Jun; 17 Suppl 1():56-66. PubMed ID: 8088226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of abnormal glucose homeostasis and insulin resistance in Turkish obese children and adolescents.
    Atabek ME; Pirgon O; Kurtoglu S
    Diabetes Obes Metab; 2007 May; 9(3):304-10. PubMed ID: 17391156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postpartum management for gestational diabetes mellitus: policy and practice implications.
    Kapustin JF
    J Am Acad Nurse Pract; 2008 Nov; 20(11):547-54. PubMed ID: 19128338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors accounting for the rise in health-care spending in the United States: the role of rising disease prevalence and treatment intensity.
    Thorpe KE
    Public Health; 2006 Nov; 120(11):1002-7. PubMed ID: 17030050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired glucose tolerance in obese children and adolescents.
    Goran MI
    N Engl J Med; 2002 Jul; 347(4):290-2; author reply 290-2. PubMed ID: 12140309
    [No Abstract]   [Full Text] [Related]  

  • 35. Consequences of high incarceration rate and high obesity prevalence on the prison system.
    Leddy MA; Schulkin J; Power ML
    J Correct Health Care; 2009 Oct; 15(4):318-27. PubMed ID: 19633334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy.
    Hoffman-Snyder C; Smith BE; Ross MA; Hernandez J; Bosch EP
    Arch Neurol; 2006 Aug; 63(8):1075-9. PubMed ID: 16769858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study.
    Hu D; Fu P; Xie J; Chen CS; Yu D; Whelton PK; He J; Gu D;
    Diabetes Res Clin Pract; 2008 Aug; 81(2):250-7. PubMed ID: 18495287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of diagnosed and undiagnosed diabetes mellitus and impaired fasting glucose in Sardinia.
    Muntoni S; Atzori L; Mereu R; Manca A; Satta G; Gentilini A; Bianco P; Baule A; Baule GM; Muntoni S
    Acta Diabetol; 2009 Sep; 46(3):227-31. PubMed ID: 19107322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.